Ewelina is a graduate of biotechnology at the University of Silesia in Katowice and she defended her doctorate at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wrocław. During her studies, she investigated the processes related to programmed cell death, in particular the participation of Bcl-2 proteins in programmed death of cancer cells and the interactions between apoptosis, necrosis, and autophagy in cells under oxidative stress. After her doctorate, she worked in pharmaceutical and medical device companies, where she was responsible for planning and implementing R&D projects, product development and clinical evaluation of medical devices. Ewelina successfully planned and coordinated the course and publication of the results of a medical experiment with the participation of patients, in which the operation of an innovative medical device for telemedicine was evaluated.
Meet our team
Pure Biologics comprises a team of extremely talented and energetic people who pursue their goals with passion. Our team consists of employees with broad competences and extensive experience gained in research units from around the world.
Niina obtained her doctorate at Karolinska Institute in Sweden in tumor biology. After post-doctoral studies, she worked at several biotech companies, like: Bioinvent International, Alligator Bioscience (Sweden) and Molecular Partners (Swtitzerland), mainly focusing on immuno-oncology and preclinical drug development. During her career, Niina has headed several departments and have taken part in the development of multiple I/O assets, like: BI-505, Mitazalizumab, ATOR-1015, ATOR-1017, ALG.APV-527, MP0310, MP0317, and MP420. Niina is a co-inventor and co-author of several patents and publications. After her last position in a start-up company in Belgium, Niina has focused on consultancy of preclinical drug development.
Martyna is a graduate of the Faculty of Biological Sciences at the University of Wrocław and Executive MBA studies at the Polish-American School of Business. She joined Pure Biologics in 2015. She participated in processes related to the transformation of the company, its entry into the NewConnect market and its transition to the main market of the Warsaw Stock Exchange. She is responsible for the company’s bodies management and contacts with investors, while actively supporting the company’s finance area.
A graduate of the University of Wroclaw. He completed postgraduate studies in project management. Since 2010, IT administrator, particularly interested in network engineering, MCTNA, MCTRE, MCTSWE, UWEA. He cooperated with many companies as an external consultant, project manager for IT implementations and IT administrator.